NASDAQ:HSAQ Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis $5.28 +0.11 (+2.13%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HSAQ alerts:Sign Up Key Stats Today's Range$5.06▼$5.2850-Day Range$4.61▼$13.3152-Week Range$9.41▼$13.80Volume33,150 shsAverage Volume205,918 shsMarket Capitalization$59.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewHealth Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.Read More… My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Receive HSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter. Email Address HSAQ Stock News HeadlinesCardinal Health expands gastroenterology, diabetes businesses with two deals worth $3.9 billionNovember 12, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Exact Sciences (EXAS) and Crispr Therapeutics AG (CRSP)November 6, 2024 | markets.businessinsider.comNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.November 21, 2024 | Darwin (Ad)Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your PortfolioOctober 5, 2024 | msn.comUS healthtech company Syra closes $2.1m public offeringSeptember 16, 2024 | msn.comQuest Completes Acquisition Of Select Laboratory Assets From Allina HealthSeptember 16, 2024 | markets.businessinsider.comEarnings call: CV Sciences maintains revenue, eyes growth with acquisitionsAugust 15, 2024 | investing.comCommunity Health Systems, Inc. (CYH) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | seekingalpha.comSee More Headlines HSAQ Stock Analysis - Frequently Asked Questions How have HSAQ shares performed this year? Health Sciences Acquisitions Co. 2's stock was trading at $9.13 at the beginning of 2024. Since then, HSAQ shares have decreased by 42.2% and is now trading at $5.28. View the best growth stocks for 2024 here. When did Health Sciences Acquisitions Co. 2 IPO? Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays served as the underwriters for the IPO. How do I buy shares of Health Sciences Acquisitions Co. 2? Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings IV (GHIV), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU). Company Calendar Today11/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:HSAQ CUSIPN/A CIK1814114 WebN/A PhoneN/AFaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-380,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-2.38% Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.61 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.62) per share Price / Book-8.52Miscellaneous Outstanding Shares11,212,000Free Float8,757,000Market Cap$59.20 million OptionableNot Optionable Beta0.09 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:HSAQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.